#1 Clinical Trials Search in Europe

Pyridoxine

This article delves into the diverse applications of pyridoxine, also known as vitamin B6, in various clinical trials. Researchers are investigating its potential benefits in treating conditions such as tardive dyskinesia, primary hyperoxaluria, obsessive-compulsive disorder, and hand-foot syndrome. The trials explore pyridoxine’s effects on different aspects of health, from neurological disorders to metabolic conditions, showcasing its versatility as a therapeutic agent.

Table of Contents

What is Pyridoxine?

Pyridoxine, also known as Vitamin B6, is an essential nutrient that plays a crucial role in various bodily functions. It is a water-soluble vitamin that helps in the metabolism of proteins, fats, and carbohydrates. Pyridoxine is also important for brain development and function, as well as the production of hormones and red blood cells[1].

Medical Conditions Treated with Pyridoxine

Pyridoxine has been studied and used in the treatment of several medical conditions:

  • Tardive Dyskinesia: This is a movement disorder that can occur as a side effect of long-term use of certain medications, particularly antipsychotics. Research has shown that pyridoxine may be effective in treating tardive dyskinesia[1].
  • Primary Hyperoxaluria Type I: This is a rare genetic disorder that leads to increased production of oxalate in the body, causing kidney stones and potentially kidney failure. Pyridoxine has been studied as a treatment for this condition[2].
  • Obsessive-Compulsive Disorder (OCD): Some research suggests that pyridoxine may help improve symptoms of OCD when used alongside standard treatments[3].
  • Lactation Suppression: Pyridoxine has been studied as a potential alternative to other medications for suppressing milk production in women who choose not to breastfeed[4].
  • Hand-Foot Syndrome: This is a side effect of certain chemotherapy drugs that causes redness, swelling, and pain in the palms of the hands and soles of the feet. Pyridoxine has been investigated as a preventive treatment for this condition[5][7].

Dosage and Administration

The dosage of pyridoxine varies depending on the condition being treated and the specific study protocol. Here are some examples from the clinical trials:

  • For tardive dyskinesia: 1200 mg per day for 12 weeks[1]
  • For primary hyperoxaluria type I: Starting at 5 mg per kg body weight per day, increasing up to 20 mg per kg body weight per day[2]
  • For OCD: 25 mg twice daily for 8 weeks[3]
  • For lactation suppression: 200 mg three times per day for a week[4]
  • For preventing hand-foot syndrome: 100 mg twice daily[5]

It’s important to note that these dosages are specific to clinical trials and may not be appropriate for general use. Always consult with a healthcare provider before starting any new supplement regimen.

Potential Side Effects

While pyridoxine is generally considered safe, high doses may cause side effects. In the clinical trials reviewed, specific side effects were not prominently mentioned. However, it’s worth noting that pyridoxine was often compared favorably to other medications in terms of side effect profiles[4].

As with any medication or supplement, it’s important to discuss potential side effects with your healthcare provider before starting treatment with pyridoxine.

Ongoing Research and Potential Applications

Researchers continue to explore new potential uses for pyridoxine:

  • Behavioral Side Effects of Levetiracetam: Levetiracetam is an anti-epileptic medication. A study is investigating whether pyridoxine can help reduce the behavioral side effects associated with this drug[6].
  • Exercise Pressor Reflex in Ischemia-Reperfusion: This complex-sounding term refers to the body’s response to exercise after a period of reduced blood flow followed by restored blood flow. Researchers are studying whether pyridoxine can help minimize the amplified blood pressure response to exercise in these conditions[8].

These ongoing studies highlight the continued interest in pyridoxine as a potential treatment for various medical conditions. As research progresses, we may discover even more applications for this versatile vitamin.

Condition Pyridoxine Application Key Findings/Objectives
Tardive Dyskinesia 1200 mg/day for 12 weeks Investigating pyridoxal kinase activity and effectiveness of vitamin B6 in treating tardive dyskinesia
Primary Hyperoxaluria Type I 5-20 mg/kg/day for 24 weeks Analyzing reduction in urinary oxalate excretion with increasing doses of pyridoxal-phosphate
Obsessive-Compulsive Disorder 25 mg twice daily for 8 weeks Assessing pyridoxine as add-on therapy to standard OCD treatment
Hand-Foot Syndrome 100 mg twice daily Evaluating pyridoxine’s ability to prevent hand-foot syndrome in cancer patients receiving capecitabine
Lactation Suppression 200 mg three times daily for a week Comparing effectiveness of pyridoxine to cabergoline for lactation suppression

FAQ

  • What is pyridoxine and why is it being studied in clinical trials? Pyridoxine is another name for vitamin B6. It's being studied in clinical trials because of its potential to help with various health conditions, including neurological disorders, metabolic diseases, and side effects of certain medications.
  • Can pyridoxine help with tardive dyskinesia? Yes, some studies are investigating pyridoxine's potential to treat tardive dyskinesia. One trial is looking at how pyridoxine levels in the body might be related to this condition and whether vitamin B6 supplementation could be an effective treatment.
  • How is pyridoxine being tested for obsessive-compulsive disorder (OCD)? In a clinical trial for OCD, researchers are testing pyridoxine as an add-on therapy to standard treatment. They're investigating whether adding vitamin B6 to regular OCD medication might improve symptoms more than standard treatment alone.
  • Is pyridoxine being studied for any rare diseases? Yes, pyridoxine is being studied for primary hyperoxaluria type I, a rare inherited disorder. Researchers are looking at whether different doses of pyridoxine can help reduce the amount of oxalate in urine, which is a key problem in this condition.
  • Can pyridoxine help with side effects of cancer treatment? Some studies are exploring whether pyridoxine can help prevent or reduce hand-foot syndrome, a side effect of certain cancer treatments like capecitabine. Researchers are comparing vitamin B6 to placebo to see if it can help manage this condition.

Ongoing Clinical Trials on Pyridoxine

  • Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Pyridoxine: Also known as vitamin B6, it's a water-soluble vitamin that plays a crucial role in various bodily functions, including metabolism, nerve function, and the production of red blood cells.
  • Tardive Dyskinesia: A neurological disorder characterized by involuntary, repetitive body movements, often caused as a side effect of long-term use of certain psychiatric medications.
  • Primary Hyperoxaluria Type I: A rare inherited disorder that causes the body to produce too much oxalate, leading to kidney and bladder stones and potentially kidney damage.
  • Obsessive-Compulsive Disorder (OCD): A mental health condition characterized by recurring, unwanted thoughts (obsessions) and/or repetitive behaviors (compulsions).
  • Hand-Foot Syndrome: A side effect of some cancer treatments, characterized by redness, swelling, and pain on the palms of the hands and/or the soles of the feet.
  • Placebo: An inactive substance or treatment used in clinical trials to compare the effects of a real drug or treatment.
  • Bioequivalence: The property of two drug products having the same rate and extent of absorption when administered at the same dose under similar conditions.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Double-blind study: A type of clinical trial where neither the participants nor the researchers know who is receiving the actual treatment and who is receiving a placebo.
  • Pyridoxal 5'-phosphate (PLP): The active form of vitamin B6 in the body, which plays a crucial role in many enzymatic reactions.

References

  1. https://clinicaltrials.gov/study/NCT01908452
  2. https://clinicaltrials.gov/study/NCT01281878
  3. https://clinicaltrials.gov/study/NCT06244121
  4. https://clinicaltrials.gov/study/NCT05024422
  5. https://clinicaltrials.gov/study/NCT00767689
  6. https://clinicaltrials.gov/study/NCT05008354
  7. https://clinicaltrials.gov/study/NCT00446147
  8. https://clinicaltrials.gov/study/NCT06369350